Phase I/II Study of Linperlisib in Combination With Chidamide for Relapsed and Refractory Peripheral T-cell Lymphoma: a Prospective, Multi-center Study
Latest Information Update: 18 Oct 2023
At a glance
- Drugs Linperlisib (Primary) ; Tucidinostat (Primary)
- Indications Anaplastic large cell lymphoma; Peripheral T-cell lymphoma; T-cell lymphoma
- Focus Adverse reactions; Therapeutic Use
Most Recent Events
- 18 Oct 2023 New trial record